Murburg M M, Villacres E C, Ko G N, Veith R C
Geriatrics Research, Education, and Clinical Center, Seattle Veterans Administration Medical Center, Washington.
J Clin Endocrinol Metab. 1991 Oct;73(4):861-5. doi: 10.1210/jcem-73-4-861.
The alpha 2-adrenergic receptor antagonist yohimbine is often used as a neuroendocrine probe in human studies, in which it is assumed to increase plasma norepinephrine (NE) by increasing sympathetic outflow. In this study we have tested that assumption by using a radioisotope dilution technique to measure norepinephrine (NE) kinetics in arterialized plasma after administration of oral yohimbine (20 or 40 mg) or placebo to normal young men. In agreement with previous studies, we found that yohimbine causes dose-dependent increases in blood pressure, heart rate, and plasma NE. We further found that the increase in plasma NE is, in fact, due to an increase in the rate of appearance of NE into plasma and not to reduced NE clearance from plasma. In addition, we found that yohimbine causes a dose-dependent increase in plasma epinephrine, which had not been found in studies measuring catecholamines in venous plasma. We conclude that yohimbine increases plasma NE levels by increasing the rate of NE release from sympathetic nerves, and probably increases epinephrine release from the adrenals.
α2 - 肾上腺素能受体拮抗剂育亨宾常用于人体研究中的神经内分泌探针,在这些研究中,假定它通过增加交感神经输出量来提高血浆去甲肾上腺素(NE)水平。在本研究中,我们通过使用放射性同位素稀释技术,对正常年轻男性口服育亨宾(20或40毫克)或安慰剂后动脉化血浆中的去甲肾上腺素(NE)动力学进行测量,从而验证了这一假设。与先前的研究一致,我们发现育亨宾会导致血压、心率和血浆NE呈剂量依赖性增加。我们进一步发现,血浆NE的增加实际上是由于NE进入血浆的速率增加,而不是血浆中NE清除率降低。此外,我们发现育亨宾会导致血浆肾上腺素呈剂量依赖性增加,这在静脉血浆中儿茶酚胺测量研究中未曾发现。我们得出结论,育亨宾通过增加交感神经NE释放速率来提高血浆NE水平,并且可能增加肾上腺的肾上腺素释放。